Jim Cramer Discussed These 16 Stocks Recently

Page 5 of 15

11. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Number of Hedge Fund Holders: 59

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the 16 stocks that Jim Cramer recently discussed. When a caller asked about the company during the lightning round, Cramer remarked:

“You know what, BioMarin, I am getting tired of the orphan drug model. I just… [don’t] think that it’s working. I think it worked for some time. I don’t think it works now.”

BioMarin (NASDAQ:BMRN) is a biotechnology company focused on turning genetic research into treatments that significantly improve patients’ lives, supported by a history of innovation and a growing pipeline of therapies. It is worth noting that in 2023, when Cramer was asked about the company during a lightning round, he commented, “I would hold onto that one.” Since the comment was aired back in January 2023, BMRN stock has gone down more than 49%.

Page 5 of 15